Delve into our extensive collection of clinically published studies showcasing real-world evidence.
Viz™ LVO
Consistent with our initial 6 month post-implementation pilot, we noted sustainability over a 17 month period with sustained reduction in...
Feb 02, 2023
Viz™ LVO
In a multi-center cluster randomized trial, implementation of an automated LVO detection software with care team-wide communication did not significantly...
Feb 02, 2023
Viz™ LVO
In a multi-center cluster randomized trial, implementation of an automated LVO detection algorithm improved treatment times [median DTG] in patients...
Feb 02, 2023
Viz™ LVO
There was a prominent reduction in CTA performed in the United States due to contrast media shortage. However, the proportion...
Feb 02, 2023
Viz™ LVO
Comparison of scores for identifying patients with vertebrobasilar occlusions who may benefit from EVT. CLEOS can predict risk of poor...
Jan 09, 2023
Viz™ LVO
Background The Viz.ai artificial intelligence (AI) software module Viz large‐vessel occlusion (LVO) utilizes AI‐powered LVO detection and triage technology to...
Sep 07, 2022
Viz™ LVO
Background Comprehensive Stroke Centers (CSCs) strive to narrow rt-PA and “Door To Groin” (DTG) neurointerventional (NIR) times. Process improvement workflows...
Feb 03, 2022
Viz™ LVO
Background Viz.AI LVO is an artificial-intelligence platform which analyzes brain computed tomography angiography (CTA) images in patients with suspected acute...
Feb 03, 2022
Viz™ LVO
Background Artificial intelligence (AI) software is increasingly applied in stroke diagnostics. However, the actual performance of AI tools for identifying...
Jan 27, 2022
